Recently, Johnson & Johnson Medical Technology (New York Stock Exchange code:JNJ) officially announced the launchKincise 2Automatic Electric Surgical Tool System. The introduction of this innovative system marks an important step forward for Johnson & Johnson's medical technology in the field of surgical instruments.

Kincise 2The Surgical Automatic Electric Tool System is the next-generation product meticulously designed by Johnson & Johnson Medical Technology, aimed at improving the efficiency of various surgical procedures and providing surgeons with more precise control.。In primary and revision hip arthroplasty as well as revision knee arthroplasty scenarios, compared with traditional manual embolic tools,Kincise 2Effectively reduce the physical burden on surgeons.

Currently, operating rooms are facing numerous challenges. Surgical durations are continuously extending, and the volume of surgeries is steadily increasing, which puts greater pressure on surgeons performing repetitive and high-intensity tasks, such as repeatedly striking a mallet, making them prone to work-related musculoskeletal pain. Johnson & Johnson Medical Technologies敏锐地捕捉到这一痛点，研发出Kincise 2System, to address these challenges.

Kincise 2Built on the foundation of the stable functions of the first-generation system, it has been comprehensively upgraded.The new version features an enhanced reverse energy and push-lock adapter, which greatly upgrades the surgical workflow and experience. Additionally, it offers an acetabular cup extraction function, making it...Kincise 2Becoming the first and only automated impactor approved for the removal of well-fixed acetabular components.This unique feature not only expands the system's role and versatility in complex hip revision surgeries but also further enhances its compatibility with advanced techniques, such as the anterior approach.

Chairman of the Orthopedics Group, Johnson & Johnson Medical TechnologyAldo DentiSaid: "Kincise 2The system reflects our demand-based innovations for orthopedics this year. As more and more patients are undergoing joint replacement surgeries earlier in life, the demand for revision surgeries is continuously increasing.Kincise "The system has proven to help surgeons manage these complex cases by reducing operation time and providing procedural control, ultimately leading to better outcomes for patients."

Currently,Kincise 2The system has officially launched in the United States. This innovative product is expected to bring positive changes to orthopedic surgeries in the U.S. and even globally, improving surgical quality, enhancing the working environment for surgeons, and providing patients with better treatment experiences and outcomes. We will also continue to monitor the system's clinical application and feedback worldwide.